Stocks futures are pointing to a lower open today on Wall Street. Among specific stocks in focus today are specialty drug company Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE), tech name BlackBerry Ltd (NASDAQ:BBRY), and organic foods manufacturer Hain Celestial Group Inc (NASDAQ:HAIN). Here's a closer look at what's moving shares of ZYNE, BBRY, and HAIN.
Zynerba Pharmaceuticals stock is up 68.3% at $10.42 after the company's cannabis-based gel met its goals in a mid-stage study. This comes just a month the stock gapped lower on disappointing drug-study results, with ZYNE shares hitting an annual low of $5.42 on Aug. 14.
A number of short sellers apparently saw the writing on the wall and got out of dodge. For example, short interest on Zynerga declined by 32.1% in the last two reporting periods, but more than one-fifth of the equity's float is still controlled by these bears.
BlackBerry this morning reported better-than-expected earnings and raised its full-year sales outlook, sending the shares 12.4% higher to $10.38 It's been a huge year for the stock, which was already up 34% year-to-date as of last night's close. Considering the fundamental and technical strength, it would seem BBRY could be in store for bullish notes from the brokerage bunch. At the moment, just one of seven analysts say to buy the security, and today's pending price action would put the shares above their average 12-month price target of $9.74.
Hain Celestial stock is up 5% at $42.40 thanks to news the company has come to an agreement with activist investor Engaged Capital to overhaul its board, opening the door for a sale of the company down the road. HAIN shares have been bouncing around the charts in 2017, but are currently holding on to a slim year-to-date lead.
In the meantime, call buyers have been blasting the stock. Its 10-day put/call volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) stands at a brow-raising 10.82, which marks a 52-week peak.